cemka > Publications > Rheumatology

Sort publications on year

  • Biometry and database analysis

    Trends in postmenopausal osteoporosis treatment in France during the period 2007-2016: A nationwide claim database analysis.

    CORTET B, SCHOTT AM, DESAMERICQ G, CHAUNY JV, SAMAMA P, EMERY C, FAGNANI F.

    Bone ; 2022;154:116255

  • Pharmaco - Epidemiology

    Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.

    SARAUX A, COMBE B, FAGNANI F, CUKIERMAN G, BRU I, JOUBERT J.-M , SCHULLER J.-C, MASSOL J, FLIPO R.-M

    Clinical and Experimental Rheumatology ; 2020(Online)

  • Biometry and database analysis

    Profile of Women Initiated on Denosumab and Pattern of Use in a Restricted Postmenopausal Osteoporosis Indication: A French Database Analysis Over the Period 2013-2014.

    EMERY C, GOURMELEN J, FAGNANI F, SUZAN F, DESAMERICQ G, FARDELLONE P.

    Adv Ther ; 2019;36(4),969-975

  • Pharmaco-Economics

    Burden of severe spondyloarthritis in France: A nationwide assessment of prevalence, associated comorbidities and cost.

    CLAUDEPIERRE P, FAGNANI F, CUKIERMAN G, DE CHALUS T, JOUBERT JM, LAURENDEAU C, GOURMELEN J, BREBAN M

    Joint Bone Spine ; 2019;86(1);69-75

  • Pharmaco - Epidemiology

    Epidemiology, impact, management and cost of Paget’s disease of bone in France

    SARAUX A, BRUN-STRANG C, MIMAUD V, VIGNERON AM, LAFUMA A

    Joint Bone Spine ; 74(1):90-95

  • Pharmaco-Economics

    A model of the public health impact of improved treatment persistence in post-meopausal osteoroposis in France

    COTTE FE, CORTET B, LAFUMA A, AVOUAC B, HASNAOUI AE, FADELLONE P, POUCHAIN D, ROUX C, GAUDIN AF

    Joint Bone Spine ; 31

  • Pharmaco-Economics

    Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries

    BOUEE S, LAFUMA A, FAGNANI F, MEUNIER PJ, REGINSTER JY

    Rheumatol Int ; 26(12):1063-72

  • Pharmaco - Epidemiology

    Costs of rheumatoid arthritis in France : a multicenter study of 1109 patients managed by hospital-based rheumatologists

    GUILLEMIN F, DURIEUX S, DAURES JP, LAFUMA A, SARAUX A, SIBILIA J, BOURGEOIS P, SANY J

    J Rheumatol ; 31(7):1297-1304

  • Pharmaco - Epidemiology

    Characteristics of patients with rheumatoid arthritis in France : a study of 1109 patients managed by hospital based rhumatologists

    SANY J, BOURGEOIS P, SARAUX A, DURIEUX S, LAFUMA A, DAURES JP, GUILLEMIN F, SIBILIA J

    Ann Rheum Dis ; 63(10):1235-1240

  • Pharmaco - Epidemiology

    Prevalence of Gout in the Adult Population of France.

    BARDIN T, BOUEE S, CLERSON P, CHALES G, FLIPO RM, LIOTE F, PEREZ V, POIRAUD T, SCHAEVERBEKE T, RICHETTE P.

    Arthritis Care Res ; 2016;68(2):261-6

  • Pharmaco - Epidemiology

    Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study

    BERTIN P, FAGNANI F, DUBURCQ A, WORONOFF AS, CHAUVIN P, CUKIERMAN G, TROPÉ-CHIROL S, JOUBERT JM, KOBELT G

    Joint Bone Spine ; 2016;86(1):47-52

  • Pharmaco - Epidemiology

    Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.

    RICHETTE P, CLERSON P, BOUÉE S, CHALÈS G, DOHERTY M, FLIPO RM, LAMBERT C, LIOTE F, POIRAUD T, SCHAEVERBEKE T, BARDIN T.

    2015 - Ann Rheum Dis ; 74 - 9 : 1684-1690

  • Pharmaco - Epidemiology

    Biomechanical and psychosocial work exposures and musculoskeletal symptoms among vineyard workers

    BERNARD C, COUROUVE L, BOUEE S, ADJEMIAN A, CHRETIEN JC, NIEDHAMMER I

    J Occup Health ; 2011;53:297-311